Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Gompels
Dual Therapy With Renally Adjusted Lamivudine and Dolutegravir: A Switch Strategy to Manage Comorbidity and Toxicity in Older, Suppressed Patients?
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Related publications
Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Dolutegravir/Abacavir/Lamivudine Versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients
PLoS ONE
Multidisciplinary
An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy
PLoS ONE
Multidisciplinary
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Patient‐Reported Comorbidity and Survival in Older Adults With Cancer
Oncologist
Cancer Research
Medicine
Oncology
Cardiovascular Comorbidity in Multiple Sclerosis Patients Treated With Mitoxantrone Therapy: A Cohort Study
Multiple Sclerosis and Demyelinating Disorders
Allergy
Immunology
Neurology
Reduced Toxicity Breast Cancer Therapy: Changing the or to and in Dual Targeted Therapeutics
Erratum To: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
Digestive Diseases and Sciences
Physiology
Gastroenterology
